183 related articles for article (PubMed ID: 21703569)
1. CDP-choline as a biological supplement during neurorecovery: a focused review.
Arenth PM; Russell KC; Ricker JH; Zafonte RD
PM R; 2011 Jun; 3(6 Suppl 1):S123-31. PubMed ID: 21703569
[TBL] [Abstract][Full Text] [Related]
2. CDP-choline: pharmacological and clinical review.
Secades JJ; Frontera G
Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.
Conant R; Schauss AG
Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642
[TBL] [Abstract][Full Text] [Related]
4. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
Fioravanti M; Yanagi M
Cochrane Database Syst Rev; 2005 Apr; (2):CD000269. PubMed ID: 15846601
[TBL] [Abstract][Full Text] [Related]
5. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
Fioravanti M; Yanagi M
Cochrane Database Syst Rev; 2000; (2):CD000269. PubMed ID: 10796523
[TBL] [Abstract][Full Text] [Related]
6. Citicoline: pharmacological and clinical review, 2006 update.
Secades JJ; Lorenzo JL
Methods Find Exp Clin Pharmacol; 2006 Sep; 28 Suppl B():1-56. PubMed ID: 17171187
[TBL] [Abstract][Full Text] [Related]
7. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
Fioravanti M; Yanagi M
Cochrane Database Syst Rev; 2000; (4):CD000269. PubMed ID: 11034681
[TBL] [Abstract][Full Text] [Related]
8. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
Fioravanti M; Yanagi M
Cochrane Database Syst Rev; 2004; (2):CD000269. PubMed ID: 15106147
[TBL] [Abstract][Full Text] [Related]
9. Citicoline, use in cognitive decline: vascular and degenerative.
García-Cobos R; Frank-García A; Gutiérrez-Fernández M; Díez-Tejedor E
J Neurol Sci; 2010 Dec; 299(1-2):188-92. PubMed ID: 20875651
[TBL] [Abstract][Full Text] [Related]
10. A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke.
Hurtado O; Cárdenas A; Pradillo JM; Morales JR; Ortego F; Sobrino T; Castillo J; Moro MA; Lizasoain I
Neurobiol Dis; 2007 Apr; 26(1):105-11. PubMed ID: 17234423
[TBL] [Abstract][Full Text] [Related]
11. Medical treatment of amblyopia: present state and perspectives.
Campos EC; Fresina M
Strabismus; 2006 Jun; 14(2):71-3. PubMed ID: 16760111
[TBL] [Abstract][Full Text] [Related]
12. Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease.
Franco-Maside A; Caamaño J; Gómez MJ; Cacabelos R
Methods Find Exp Clin Pharmacol; 1994 Oct; 16(8):597-607. PubMed ID: 7760585
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases.
Lozano Fernández R
Arzneimittelforschung; 1983; 33(7A):1073-80. PubMed ID: 6684470
[TBL] [Abstract][Full Text] [Related]
14. Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: development of a selective alpha7 nicotinic acetylcholine receptor agonist strategy.
Deutsch SI; Rosse RB; Schwartz BL; Schooler NR; Gaskins BL; Long KD; Mastropaolo J
Eur Neuropsychopharmacol; 2008 Feb; 18(2):147-51. PubMed ID: 17656074
[TBL] [Abstract][Full Text] [Related]
15. Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations.
Cansev M; Ilcol YO; Yilmaz MS; Hamurtekin E; Ulus IH
Auton Autacoid Pharmacol; 2008 Jan; 28(1):41-58. PubMed ID: 18257750
[TBL] [Abstract][Full Text] [Related]
16. Membrane stabilizer: citicoline.
Zweifler RM
Curr Med Res Opin; 2002; 18 Suppl 2():s14-7. PubMed ID: 12365823
[TBL] [Abstract][Full Text] [Related]
17. [The current state of citicholine in cerebral ischemia].
Abad-Santos F; Gallego-Sandín S; Novalbos J; Gálvez-Múgica MA
Rev Neurol; 2000 Apr 1-15; 30(7):663-70. PubMed ID: 10859748
[TBL] [Abstract][Full Text] [Related]
18. Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: a preliminary report.
Renshaw PF; Daniels S; Lundahl LH; Rogers V; Lukas SE
Psychopharmacology (Berl); 1999 Feb; 142(2):132-8. PubMed ID: 10102764
[TBL] [Abstract][Full Text] [Related]
19. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
[TBL] [Abstract][Full Text] [Related]
20. [CDP choline and cerebrovascular insufficiency in the elderly. Clinical study of 40 patients undergoing prolonged treatment].
Merchan C; Berchicci R; Cuzzoni G; Pecorini M
Minerva Cardioangiol; 1985 Mar; 33(3):145-8. PubMed ID: 4010981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
